Bausch Health Companies BHC Acquisition-related contingent consideration
Acquisition-related contingent consideration at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept bhc:BusinessCombinationContingentConsiderationNoncurrentLiability.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's acquisition-related contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch Health Companies's acquisition-related contingent consideration?
- Bausch Health Companies (BHC) reported acquisition-related contingent consideration of $213M in Q1 2026.
- How has Bausch Health Companies's acquisition-related contingent consideration changed year-over-year?
- Bausch Health Companies's acquisition-related contingent consideration decreased by 24.5% year-over-year, from $282M to $213M.
- What is the long-term trend for Bausch Health Companies's acquisition-related contingent consideration?
- Over 5 years (2020 to 2025), Bausch Health Companies's acquisition-related contingent consideration has grown at a 3.3% compound annual growth rate (CAGR), from $216M to $254M.
- What does acquisition-related contingent consideration mean?
- This represents the estimated fair value of future payments owed to sellers of acquired businesses, contingent upon the achievement of specific performance milestones or financial targets. It serves as a measure of potential future cash outflows tied to the success of past M&A activities. Investors use this to evaluate the long-term financial risk and integration costs associated with inorganic growth strategies.